Parkworth Wealth Management’s ResMed RMD Stock Holding History

Parkworth Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.29K	Buy	5 +3	+150%	+$716	﹤0.01%	355
2025 Q1	$448	Hold	2	–	–	﹤0.01%	458
2024 Q4	$457	Buy	+2	New	+$482	﹤0.01%	460

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Parkworth Wealth Management's RMD Position: Q2 2025 in Review

Parkworth Wealth Management increased its ResMed (RMD) stake by 150% in Q2 2025, buying an estimated $716 and bringing the position to 5 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #355.

Parkworth Wealth Management first reported a position in RMD in Q4 2024 and has held it in 3 quarters since. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Parkworth Wealth Management held 5 shares of ResMed worth $1.29K as of Q2 2025.
Parkworth Wealth Management bought 3 ResMed shares in Q2 2025, an estimated $716.
ResMed made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #355 holding.
Parkworth Wealth Management first reported a position in ResMed in Q4 2024 and has held it in 3 quarters since.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.